Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioVie Inc.
  6. News
  7. All News
    BIVI   US09074F2074

BIOVIE INC.

(BIVI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about BIOVIE INC.
10/14BIOVIE : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
10/14BIOVIE INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
10/13BIOVIE : Hosting Key Opinion Leader Webinar on Neuroinflammation and Insulin Resistance an..
AQ
09/22BIOVIE : to Present at Cantor Virtual Global Healthcare Conference
AQ
09/15BioVie to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Virtual Summit
GL
08/30BIOVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERAT..
AQ
08/30Biovie Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
CI
08/30BioVie Inc. Contemplates Bankruptcy 
CI
08/11BIOVIE : Closes Common Stock Offering
MT
08/11BIOVIE : Announces Pricing of Public Offering of Common Stock (Form 8-K)
PU
08/11BIOVIE INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other ..
AQ
08/11BioVie Inc. Announces Closing of Public Offering of Common Stock
GL
08/09Top Midday Decliners
MT
08/09UPDATE : BioVie Prices Offering at $8/Share, Expects $20 Million Gross Proceeds - Shares S..
MT
08/09Top Premarket Decliners
MT
08/09BIOVIE : Prices Offering at $8/Share, Expects $20 Million Gross Proceeds
MT
08/08BioVie Inc. Announces Pricing of Public Offering of Common Stock
GL
08/06BioVie Inc. Announces Proposed Public Offering of Common Stock
GL
08/05BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/05Biovie Announces First Patient Enrolled in Phase 3 Study of Ne3107 in Alzheimer’s Disea..
CI
08/05BIOVIE : Enrolls First Patient in Phase 3 Study of NE3107 to Treat Alzheimer's Disease; Sh..
MT
08/05BIOVIE : Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer's Diseas..
AQ
07/27BIOVIE : Presents Data Supporting use of NE3107 in the Treatment of Alzheimer's Disease at..
AQ
07/22BIOVIE : to Present Rationale for use of NE3107 for the Treatment of Alzheimer's Disease a..
AQ
07/16Basis for BioVie's Phase 3 Clinical Trial of NE3107 in the Treatment of Alzheimer's Dis..
GL
07/16BioVie to Launch a Pivotal Phase 3 Trial in Alzheimer’s This Summer to Assess How Treat..
CI
06/29Development of BioVie's NE3107 Asset Featured by the American Diabetes Association
GL
06/28BIOVIE : Added to Russell Microcap® Index
AQ
06/25BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
GL
06/24BIOVIE : Enrolls First Patient in Phase 2b Trial of BIV201 to Treat Ascites
MT
06/24BIOVIE : Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites
AQ
06/24BioVie Inc. Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Asci..
CI
06/23BIOVIE : Obtains FDA Guidance for Phase 3 Clinical Study of BIV201 in Hepatorenal Syndrome..
MT
06/23BIOVIE : Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKI
AQ
06/23BioVie Inc. Receives FDA Guidance for Phase 3 Clinical Trial of Biv201 in HRS-AKI
CI
06/17BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
GL
06/11BIOVIE : Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedi..
PU
06/11BIOVIE INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Dis..
AQ
06/11BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMed..
GL
05/25BIOVIE : B. Riley Raises BioVie's PT to $50 from $47 On Liver, Neurodegenerative, and Onco..
MT
05/17BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/12BioVie Hosting Research & Development Day
GL
05/12BIOVIE : Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix (Form..
PU
05/10BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
05/10Biovie Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
CI
05/10BIOVIE INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
05/10BioVie Announces Amended Terms for Asset Acquisition from Privately Held NeurMedix
GL
04/29BIOVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/28BIOVIE : Shares Fall After Disclosing Deal to Buy NeurMedix Assets, CEO Appointment
MT
04/28Stocks Fall Ahead of Fed Rate Decision
MT
04/28MIDDAY REPORT : Wall Street Falls Ahead of Fed Rate Decision
MT
04/28BioVie to Present at 2021 B. Riley Securities' Neuroscience Conference
GL
04/27BIOVIE INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu..
AQ
04/27BIOVIE : Acquires Biopharma Assets from Privately Held NeurMedix
AQ
04/27Biovie Inc. Announces the Acquisition of the Biopharmaceutical Assets of Neurmedix, Inc
CI
04/27BioVie Inc. Announces the Appointment of Cuong V. Do as President and CEO
CI
03/17Certain Warrants of BioVie Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-202..
CI
03/17Certain Class A Common Stock of BioVie Inc. are subject to a Lock-Up Agreement Ending o..
CI
03/17Certain Options of BioVie Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2021..
CI
03/11BIOVIE : to Present at 31st Annual Oppenheimer Healthcare Conference
AQ
03/09BIOVIE : Commences Patient Screening in Phase 2 Clinical Trial
AQ
03/09BioVie Commences Patient Screening in Phase 2 Clinical Trial
CI
02/19BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
GL
01/29BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
01/29BioVie Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020
CI
01/26BIOVIE : Files Shelf of Up to $100 Million in Securities
MT
01/15BIOVIE : B. Riley Starts BioVie at Buy With $47 Price Target
MT
2020BIOVIE INC.(NASDAQCM : BIVI) added to S&P TMI Index
CI
2020Certain Class A Common Stock of BioVie Inc. are subject to a Lock-Up Agreement Ending o..
CI
2020Certain Options of BioVie Inc. are subject to a Lock-Up Agreement Ending on 17-DEC-2020..
CI
2020Certain Warrants of BioVie Inc. are subject to a Lock-Up Agreement Ending on 17-DEC-202..
CI
2020Biovie Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020
CI
2020BIOVIE : Management's Discussion and Analysis of Financial Condition and Results of Operat..
AQ
2020BIOVIE : Interview to Air on Bloomberg International on the RedChip Money Report
AQ
2020BioVie Interview to Air on Bloomberg International on the RedChip Money Report
GL
1  2Next
Upcoming event on BIOVIE INC.
10/26/21